Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-1.04 %
$ 60.6 M
Market Cap
-167.0
P/E
ICCC - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ICCC - ImmuCell Corporation
-461 K
LAST VALUE
65.89%
2 YEAR CAGR
32.95%
5 YEAR CAGR
11.33%
10 YEAR CAGR